| 103.92 BATS BZX Real-Time Price As of 2:51pm ET |  +0.28 / +0.27%Today’s Change | 100.22 Today|||52-Week Range 122.97 | -2.67% Year-to-Date |
The investment seeks to track the investment results of the NASDAQ Biotechnology Index- which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq- Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures- options and swap contracts- cash and cash equivalents. It is non-diversified.
| Eye Drug Continues to Drive Regeneron's Growth Dec 04 / GuruFocus News - Paid Partner Content |
| 1 month | -6.86% | 3 years | -1.24% | |
| 3 months | -12.08% | 5 years | +7.11% | |
| 1 year | -0.28% | Since inception | +6.72% |
| Previous close | $103.64 |
| Open day’s range | 101.27 – 104.26 |
| Net asset value (NAV) | 103.50 (12/07/2018) |
| Daily volume | 128,222 |
| Average volume (3 months) | 1,968,388 |
| IBB | Category | |
|---|---|---|
| Performance 5-yr return | +7.11% | +14.62% |
| Expense Gross exp ratio | 0.47% | 1.28% |
| Risk 5 year sharpe ratio | 0.43 | 0.76 |
| Net assets | $8.4B | $3.4B |
| Average market cap | $17.0B | $27.2B |
| Average P/E | 30.2 | 27.5 |
| Dividend / Share | -- | 0.28% |
| IHI iShares U.S. Medical Devices ETF |
| FHLC Fidelity® MSCI Health Care Index ETF |
| VHT Vanguard Health Care Index Fund ETF Shar... |
| RYH Invesco S&P 500® Equal Weight Health Ca... |
| Healthcare | 99.91% |
| Business service | 0.09% |
| Consumer goods | 0.00% |
| Consumer service | 0.00% |
| Energy | 0.00% |
| AMGN Amgen | 9.30% |
| GILD Gilead Sciences | 8.48% |
| BIIB Biogen | 8.42% |
| CELG Celgene | 6.54% |
| ILMN Illumina Inc | 6.38% |
| VRTX Vertex Pharmaceuticals Inc | 4.37% |
| REGN Regeneron Pharmaceuticals | 4.01% |
| ALXN Alexion Pharmaceuticals Inc | 3.70% |
| MYL Mylan NV | 2.35% |
| BMRN Biomarin Pharmaceutical Inc | 2.30% |
